Jeshmi Jeyabalan

868 total citations
19 papers, 637 citations indexed

About

Jeshmi Jeyabalan is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Jeshmi Jeyabalan has authored 19 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Nephrology and 6 papers in Epidemiology. Recurrent topics in Jeshmi Jeyabalan's work include Metabolism, Diabetes, and Cancer (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Parathyroid Disorders and Treatments (6 papers). Jeshmi Jeyabalan is often cited by papers focused on Metabolism, Diabetes, and Cancer (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Parathyroid Disorders and Treatments (6 papers). Jeshmi Jeyabalan collaborates with scholars based in United Kingdom, France and United States. Jeshmi Jeyabalan's co-authors include Chantal Chenu, Benoı̂t Viollet, Mittal Shah, Rajesh V. Thakker, Jean‐Paul Roux, Gerard Walls, Michael R. Bowl, Brian Harding, Pascale Chavassieux and Adam J. Reed and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jeshmi Jeyabalan

19 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeshmi Jeyabalan United Kingdom 13 308 215 154 121 104 19 637
Qiu-Hua Liang China 14 229 0.7× 67 0.3× 131 0.9× 28 0.2× 28 0.3× 16 557
J. van der Sluys Veer Netherlands 10 105 0.3× 140 0.7× 83 0.5× 136 1.1× 53 0.5× 18 480
Yujie Ma China 15 326 1.1× 143 0.7× 45 0.3× 38 0.3× 15 0.1× 30 648
Hiroki Fukuda Japan 14 309 1.0× 133 0.6× 93 0.6× 31 0.3× 116 1.1× 57 686
Pedro E. Huertas United States 9 325 1.1× 39 0.2× 70 0.5× 22 0.2× 29 0.3× 15 651
Gen Kuroyanagi Japan 14 335 1.1× 105 0.5× 55 0.4× 32 0.3× 12 0.1× 90 695
Sergiu Boțolin United States 7 502 1.6× 252 1.2× 89 0.6× 107 0.9× 5 0.0× 7 858
J Bonnet France 12 130 0.4× 70 0.3× 71 0.5× 41 0.3× 10 0.1× 17 529
Yasuo Totsuka Japan 13 324 1.1× 106 0.5× 26 0.2× 144 1.2× 7 0.1× 23 595
Azeb Haile United States 10 243 0.8× 100 0.5× 34 0.2× 71 0.6× 8 0.1× 17 555

Countries citing papers authored by Jeshmi Jeyabalan

Since Specialization
Citations

This map shows the geographic impact of Jeshmi Jeyabalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeshmi Jeyabalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeshmi Jeyabalan more than expected).

Fields of papers citing papers by Jeshmi Jeyabalan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeshmi Jeyabalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeshmi Jeyabalan. The network helps show where Jeshmi Jeyabalan may publish in the future.

Co-authorship network of co-authors of Jeshmi Jeyabalan

This figure shows the co-authorship network connecting the top 25 collaborators of Jeshmi Jeyabalan. A scholar is included among the top collaborators of Jeshmi Jeyabalan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeshmi Jeyabalan. Jeshmi Jeyabalan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Beyer, Tina, Emma Peskett, Georg Otto, et al.. (2023). De-Suppression of Mesenchymal Cell Identities and Variable Phenotypic Outcomes Associated with Knockout of Bbs1. Cells. 12(22). 2662–2662. 1 indexed citations
2.
Beyer, Tina, Jeshmi Jeyabalan, Emma Peskett, et al.. (2023). Affinity Purification of Intraflagellar Transport (IFT) Proteins in Mice Using Endogenous Streptavidin/FLAG Tags. Methods in molecular biology. 2725. 199–212. 2 indexed citations
3.
Lines, Kate E, Mark Stevenson, Radu Mihai, et al.. (2021). Hypoxia stimulates angiogenesis and a metabolic switch in human parathyroid adenoma cells. SHILAP Revista de lepidopterología. 1(1). 23–32. 1 indexed citations
4.
Geerlings, Maartje J., Jeshmi Jeyabalan, Peter Scambler, et al.. (2018). An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis. Molecular Syndromology. 10(1-2). 98–114. 10 indexed citations
5.
Walls, Gerard, Mark Stevenson, Kate E Lines, et al.. (2017). Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome. Oncogene. 36(28). 4025–4036. 28 indexed citations
6.
Vernon, Jeffrey, Elaine E. Irvine, Marco Peters, Jeshmi Jeyabalan, & Karl-Peter Giese. (2016). Phosphorylation of K+ channels at single residues regulates memory formation. Learning & Memory. 23(4). 174–181. 5 indexed citations
7.
Pereira, Marie, Jeshmi Jeyabalan, Mark Hopkinson, et al.. (2015). Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice. Bone. 81. 459–467. 113 indexed citations
8.
Jeyabalan, Jeshmi, Benoı̂t Viollet, Peter Smitham, et al.. (2013). The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing. Osteoporosis International. 24(10). 2659–2670. 77 indexed citations
9.
10.
Walls, Gerard, Manuel C. Lemos, Miriam Bazán‐Peregrino, et al.. (2012). MEN1 Gene Replacement Therapy Reduces Proliferation Rates in a Mouse Model of Pituitary Adenomas. Cancer Research. 72(19). 5060–5068. 23 indexed citations
11.
Gupta, Ramesh C., Sukhvinder S. Bansal, Farrukh Aqil, et al.. (2012). Controlled-release systemic delivery - a new concept in cancer chemoprevention. Carcinogenesis. 33(8). 1608–1615. 36 indexed citations
12.
Esapa, Christopher T., Rosie Head, Jeshmi Jeyabalan, et al.. (2012). A Mouse with an N-Ethyl-N-Nitrosourea (ENU) Induced Trp589Arg Galnt3 Mutation Represents a Model for Hyperphosphataemic Familial Tumoural Calcinosis. PLoS ONE. 7(8). e43205–e43205. 31 indexed citations
13.
Walls, Gerard, Adam J. Reed, Jeshmi Jeyabalan, et al.. (2012). Proliferation Rates of Multiple Endocrine Neoplasia Type 1 (MEN1)-Associated Tumors. Endocrinology. 153(11). 5167–5179. 13 indexed citations
14.
Jeyabalan, Jeshmi, Mittal Shah, Benoı̂t Viollet, & Chantal Chenu. (2011). AMP-activated protein kinase pathway and bone metabolism. Journal of Endocrinology. 212(3). 277–290. 97 indexed citations
15.
Jeyabalan, Jeshmi, M. Andrew Nesbit, Juris Galvanovskis, et al.. (2010). SEDLIN Forms Homodimers: Characterisation of SEDLIN Mutations and Their Interactions with Transcription Factors MBP1, PITX1 and SF1. PLoS ONE. 5(5). e10646–e10646. 21 indexed citations
16.
Walls, Gerard, Michael R. Bowl, Jeshmi Jeyabalan, et al.. (2009). Mice deleted for the hyperparathyroidism-jaw tumour (HPT-JT) syndrome allele have abnormal parathyroids with increased proliferation rates. 19. 1 indexed citations
17.
Lemos, Manuel C., Brian Harding, Adam J. Reed, et al.. (2009). Genetic background influences embryonic lethality and the occurrence of neural tube defects in Men1 null mice: relevance to genetic modifiers. Journal of Endocrinology. 203(1). 133–142. 29 indexed citations
18.
Harding, Brian, Manuel C. Lemos, Adam J. Reed, et al.. (2009). Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia. Endocrine Related Cancer. 16(4). 1313–1327. 76 indexed citations
19.
Newey, Paul, Jeshmi Jeyabalan, Gerard Walls, et al.. (2009). Asymptomatic Children with Multiple Endocrine Neoplasia Type 1 Mutations May Harbor Nonfunctioning Pancreatic Neuroendocrine Tumors. The Journal of Clinical Endocrinology & Metabolism. 94(10). 3640–3646. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiu-Hua Liang Breakdown of academic impact, for papers by J. van der Sluys Veer Breakdown of academic impact, for papers by Yujie Ma Breakdown of academic impact, for papers by Hiroki Fukuda Breakdown of academic impact, for papers by Pedro E. Huertas Breakdown of academic impact, for papers by Gen Kuroyanagi Breakdown of academic impact, for papers by Sergiu Boțolin Breakdown of academic impact, for papers by J Bonnet Breakdown of academic impact, for papers by Yasuo Totsuka Breakdown of academic impact, for papers by Azeb Haile
Rankless by CCL
2026